Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Stephen J. Elledge, Ph.D.

Title
Institution
Department
Address
Phone
Fax
Other Positions
Title
Institution
Department

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01CA234600 (ELLEDGE, STEPHEN J) Jan 1, 2019 - Dec 31, 2023
    NIH/NCI
    Analysis of the Mammalian DNA Damage Response
    Role: Principal Investigator
  2. U01CA199252 (HAIGIS, KEVIN MICHAEL) Sep 25, 2015 - Aug 31, 2020
    NIH/NCI
    A multi-faceted approach to identifying K-Ras synthetic lethal relationships
    Role: Principal Investigator
  3. U24AI118633 (LARMAN, HARRY BENJAMIN) Jun 22, 2015 - May 31, 2020
    NIH/NIAID
    Development of Highly Multiplex Antigen Specificity Assays
    Role: Principal Investigator
  4. R33CA140039 (ELLEDGE, STEPHEN J) Aug 1, 2009 - Jul 31, 2013
    NIH/NCI
    A multiplex genome-wide shRNA screening platform for cancer-lethal gene discovery
    Role: Principal Investigator
  5. U19AI067751 (D'ANDREA, ALAN DAVID) Aug 31, 2005 - Jul 31, 2011
    NIH/NIAID
    Centers for Medical Countermeasures Against Radiation
    Role: Co-Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Guerra SL, Maertens O, Kuzmickas R, De Raedt T, Adeyemi RO, Guild CJ, Guillemette S, Redig AJ, Chambers ES, Xu M, Tiv H, Santagata S, Jänne PA, Elledge SJ, Cichowski K. A Deregulated HOX Gene Axis Confers an Epigenetic Vulnerability in KRAS-Mutant Lung Cancers. Cancer Cell. 2020 Mar 19. PMID: 32243838.
    Citations:    
  2. Bruno PM, Lu M, Dennis KA, Inam H, Moore CJ, Sheehe J, Elledge SJ, Hemann MT, Pritchard JR. The primary mechanism of cytotoxicity of the chemotherapeutic agent CX-5461 is topoisomerase II poisoning. Proc Natl Acad Sci U S A. 2020 Feb 25; 117(8):4053-4060. PMID: 32041867.
    Citations:    
  3. Heo JM, Harper NJ, Paulo JA, Li M, Xu Q, Coughlin M, Elledge SJ, Harper JW. Integrated proteogenetic analysis reveals the landscape of a mitochondrial-autophagosome synapse during PARK2-dependent mitophagy. Sci Adv. 2019 11; 5(11):eaay4624. PMID: 31723608.
    Citations:    
  4. Mina MJ, Kula T, Leng Y, Li M, de Vries RD, Knip M, Siljander H, Rewers M, Choy DF, Wilson MS, Larman HB, Nelson AN, Griffin DE, de Swart RL, Elledge SJ. Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens. Science. 2019 11 01; 366(6465):599-606. PMID: 31672891.
    Citations:    
  5. Elman JS, Ni TK, Mengwasser KE, Jin D, Wronski A, Elledge SJ, Kuperwasser C. Identification of FUBP1 as a Long Tail Cancer Driver and Widespread Regulator of Tumor Suppressor and Oncogene Alternative Splicing. Cell Rep. 2019 Sep 24; 28(13):3435-3449.e5. PMID: 31553912.
    Citations: